US Pharma MarketingThe reorganization comes months after Fred Lowery was named CEO and the company deepened its relationship with private equity firm KKR.
Henry Schein removes 3 longtime execs in leadership shakeup
The reorganization comes months after Fred Lowery was named CEO and the company deepened its relationship with private equity firm KKR.
Source: MedTech Dive